v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 14,111 $ 17,720
Prepaid expenses and other current assets 1,580 1,716
Total current assets 15,691 19,436
Other 68 96
Total assets 15,759 19,532
Current liabilities:    
Accounts payable 3,121 3,245
Accrued expenses 4,186 4,722
Accrued dividends payable 0 63
Total current liabilities 7,307 8,030
Convertible notes payable and accrued interest, net of debt discounts – related party (Note 5) 32,878 32,702
Derivative liabilities (Note 6) 2,979 3,962
Borrowing and accrued interest under convertible line of credit, net of debt discount – related party (Note 10) 102,832 101,033
Total liabilities 145,996 145,727
Commitments and contingencies (Note 12)
Series C 6% super dividend redeemable convertible preferred stock; 1,000 shares authorized, 176 issued and outstanding at March 31, 2026 and December 31, 2025, redemption value: $7,966,000, liquidation value: $1,760,000 at March 31, 2026 1,723 1,723
Undesignated stock, $0.01 par value; 20,000,000 shares authorized at March 31, 2026 and December 31, 2025 20,000,000 shares designated at March 31, 2026 and December 31, 2025, respectively 0 0
Series A 12% convertible preferred stock; 1,742,500 shares authorized, 1,185,000 and 1,210,000 issued and outstanding at March 31, 2026 and December 31, 2025, respectively, liquidation value $1,210,000 at March 31, 2026 480 490
Common stock, $0.001 par value; 150,000,000 shares authorized at March 31, 2026 and December 31, 2025, 65,856,898 and 65,201,995 issued and outstanding at March 31, 2026 and December 31, 2025, respectively 65 65
Additional paid-in capital 305,108 304,073
Accumulated deficit (437,613) (432,546)
Total stockholders’ deficit (131,960) (127,918)
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit $ 15,759 $ 19,532